Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Drugs and Therapy Perspectives for 2020.
This year has presented many challenges and we would like to take this opportunity to thank all who have contributed to ensuring the journal has thrived despite the extraordinary circumstances that the science community, and the world in general, has faced.
We would like to start by thanking the authors of the articles published in Drugs and Therapy Perspectives over the course of 2020. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.
The quality of published articles is also testament to the diligence of the peer reviewers, whose willingness to share their expertise ensures that the journal’s content is held to the highest standard. We would like to acknowledge the following individuals who acted as reviewers for Drugs and Therapy Perspectives in the last 12 months:
Jad Abdallah, Lebanon
Dania Abu-Naser, Jordan
Habeeb Ibrahim Abdul Razack, Saudi Arabia
Niyaz Ahmad, Saudi Arabia
Yousef Ahmed Alomi, Saudi Arabia
A. Deniz Akkaya, Turkey
Ali Aldibbiat, Kuwait
Abdullah Al Hamid, UK
Natasha Ali, Pakistan
Zainab Ali, Qatar
Abdulhadi M. Alqahtani, Saudi Arabia
Sabina A. Antoniu, Romania
Francisco Araujo, Spain
Ali Ekrem Aydin, Turkey
Marium Azim, Pakistan
Osama Badary, Egypt
Anabela Barcelos, Portugal
Anthony H. Barnett, UK
German Baron, Colombia
Kalyani Barve, India
Julio Bassas-Vila, Spain
Anthony Baughn, USA
John E. Bennett, USA
Christian Brandt, Germany
James R. Brasic, USA
Diana Brasselet, France
Paula Briggs, UK
Elena P. Calandre, Spain
Fernando Carreno, Brazil
Renato Caviglia, UK
Natalie Cebotarenco, Republic of Moldova
Osmar A. Centurion, Paraguay
Michael Ceulemans, Belgium
Athanasios Chalkias, Greece
Sonia Chavez-Alvarez, Mexico
Surarong Chinwong, Thailand
Giuseppe Cianchini, Italy
Juan Correa, USA
Rui Cruz, Portugal
Charles L. Daley, USA
Richard O. Day, Australia
Tine L. M. De Backer, Belgium
Stefano de Biase, Italy
Erik De Clercq, Belgium
Navin Kumar Devaraj, Malaysia
Costantino Di Carlo, Italy
Hassan Dib, China
Frank Doesburg, the Netherlands
Lars Edvinsson, Sweden
Shereen Elazzazy, Qatar
Ali Elbeddini, Canada
Urban Emmenegger, Canada
Marcos Escobedo-Guerra, Mexico
Tadele Eticha, Ethiopia
Rita Farah, Lebanon
Pedro J. Garcia Ruiz, Spain
Swapna Gayam, USA
Niloofar N. Ghadamyari, Islamic Republic of Iran
Micheline A. Goldwire, USA
Maria Guerrieno, Portugal
Luisa Guidi, Italy
David Hachey, Namibia
Martina Hahn, Germany
Husnain Hamid, Pakistan
Guy Hans, Belgium
Syed Shahzad Hasan, UK
Gamal Harisa, Saudi Arabia
Abdul Haseeb, Saudi Arabia
Renske Hebing, the Netherlands
Satisha Hegde, India
Raquel Herrera Comoglio, Argentina
Yuji Hirano, Japan
Swapnil Hiremath, Canada
Germain Honvo, Belgium
Robert H. Howland, USA
Bruce P. J. Hugman, Thailand
Perpetua U. Ibekwe, Nigeria
Cristoforo Incorvaia, Italy
Demetris Ioannides, Greece
Abubakar M. Isa, Nigeria
Girish K. Jain, India
Shazia Q. Jamshed, Malaysia
Narumol Jarernsiripornkul, Thailand
Jimmy Jose, Oman
Shrikant V. Joshi, India
Stylianos Karatapanis, Greece
Upinder Kaur, India
Tahir Khan, Malaysia
Hossein Khorramdelazad, Islamic Republic of Iran
Edeltraut Kröger, Canada
Chiaoyun Kuo, USA
Xiaomeng Li, USA
Ye Htut Linn, Myanmar
Wen-Shyong Liou, Taiwan, Republic of China
Chen S. Liu, China
Fanxiao Liu, China
José Lopes, Portugal
Tauqeer H. Mallhi, Saudi Arabia
Imran Manji, Kenya
Noha O. Mansour, Egypt
Maria A. P. Martins, Brazil
Khalid Masoodi, India
Yoshihiro Y. Matsukawa, Japan
Mudasir A. Mir, India
Sanja Mirkov, New Zealand
Bhautik Modi, India
Mona Mostaghim, Australia
Joaquim Mullol, Spain
Arnulfo Hernan Nava-Zavala, Mexico
David N. Neubauer, USA
Khawla Nuseir, Jordan
Santiago S. Palacios, Spain
Nikolaos Papanas, Greece
Harikrishnan Parthasarathy, India
Heverton M. Peres, Brazil
Nancy Phillips, USA
Alvaro Pinto, Spain
Rosario Pivonello, Italy
Dimitri Poddighe, Kazakhstan
Kein Boon Poon, Singapore
Yash Prashar, India
Giuseppe A. Ramirez, Italy
Mamunur Rashid, Pakistan
Muhammed Rashid, India
Saeed U. Rashid Nazir, Saudi Arabia
Christophe Richez, France
Roberto R. Riva, Italy
Leonardo Roever, Brazil
Peter P. Rossing, Denmark
Florjana Rustemi, Albania
Kourosh Sadeghi, Islamic Republic of Iran
Nida Saleem, Pakistan
Muhammad Salman, Pakistan
Sandeep Saluja, India
Asir J. Samuel, India
Hiren Sanghani, India
Luis Sargento, Portugal
Martin O. Savage, UK
Mona Schaalan, Egypt
Rima B. Shah, India
Joanne L. Sharp, UK
Leticia Shea, USA
Alok Singh, India
Caroline Sirois, Canada
Brian Spoelhof, USA
Eriko Sumi, Japan
Maysa Suyagh, Jordan
Million Adane Tegenge, USA
Zvi Teitelbaum, Israel
Mehmet E. Tezcan, Turkey
Paolo Tomasi, the Netherlands
Nurten Gizem Tore, Turkey
Shanna C. Trenaman, Canada
Thierry Trenque, France
Himi Tripathi, USA
Rakshamani Tripathi, USA
Themistoklis Tzotzas, Greece
Charlie Upton, USA
Job F. M. van Boven, the Netherlands
Kirsten K. Viktil, Norway
Francisco Vílchez-Márquez, Spain
Junming Wan, China
Ming-Shyan Wang, Taiwan, Republic of China
Susan M. Webb, Spain
H. Steve White, USA
Joshua Wiegel, USA
Thasia G. Woodworth, USA
Tien-Yuan Wu, Taiwan, Republic of China
Albert Yang, Taiwan, Republic of China
Kai Zhen Yap, Singapore
Ichiro Yoshii, Japan
Abed Zahedi Bialvaei, Islamic Republic of Iran
Ashkan Zandi, Islamic Republic of Iran
Sara Zandonella Callegher, Italy
William S. Zirker, USA
We are also very grateful to the members of the journal’s Honorary Editorial Board, who, in addition to acting as peer reviewers and/or authors, have provided guidance on journal content, policy and processes.
The COVID-19 pandemic has reinforced the importance of rapid and wide dissemination of high-quality information. Springer Nature is supporting the global response to COVID-19 by making all relevant content immediately and freely available. Indeed, Drugs and Therapy Perspectives has published a number of papers relevant to the COVID-19 pandemic that are free to access. The most popular of these, in terms of downloads from SpringerLink as at October 2020, have been:
-
Coronavirus outbreaks: prevention and management recommendations Khan Z, Muhammad K, Ahmed A, et al.
-
Is Pakistan prepared to tackle the coronavirus epidemic? Saqlain M, Munir MM, Ahmed A, et al.
-
Preventing COVID-19 in low- and middle-income countries Khadka S, Hashmi FK, Usman M.
-
Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA? Javed B, Sarwer A, Soto EB, et al.
-
Preventive measures and management of COVID-19 in pregnancy Omer S, Ali S, Babar ZD.
-
Knowledge, attitude and preventive practices related to COVID-19: a cross-sectional study in two Pakistani university populations Salman M, Mustafa ZU, Asif N, et al.
-
Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview Parreiras Martins MA, Fonseca de Medeiros A, Dias Carneiro de Almeida C, et al.
-
The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic OgarC, Mathenge W, Khaemba C, et al.
-
Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional survey. Gudi SK, Chhabra M, Undela K, et al.
-
Within a large healthcare system, the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy Sen S, Werner A, Shekhar A.
-
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 Kahn SH, Zaidi SK.
-
Current pharmacy practices in low- and middle-income countries; recommendations in response to the COVID-19 pandemic Hamid H, Masood RA, Tariq H, et al.
-
Paradigm shift of drug information centers during the COVID-19 pandemic Khatiwada AP, Shakya S, Shrestha S.
-
Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage Elbeddini A, Tayefehchamani Y, Yang L.
-
Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers Kow CS, Hasan SS.
-
Should community pharmacies provide COVID-19 screening services? Tan CH.
-
Self-medication during Covid-19 pandemic: challenges and opportunities Malik M, Tahir MJ, Jabbar R, et al.
Further, Drugs and Therapy Perspectives has published content in a timely manner, with an average time from submission to first decision of 20 days and from acceptance to online publication of 18 days.
In 2021, Drugs and Therapy Perspectives will continue to provide you with high-interest content relevant to real-world clinical settings. We thank you for your continued support.
With best wishes,
Katherine A. Lyseng-Williamson, Editor-in-Chief
Young A Heo, Associate Editor
Rights and permissions
About this article
Cite this article
Acknowledgement to referees. Drugs Ther Perspect 36, 535–538 (2020). https://doi.org/10.1007/s40267-020-00795-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-020-00795-x